Significant Pharmaceuticals Reported in US Patents - 1st Edition - ISBN: 9780080453446, 9780080480916

Significant Pharmaceuticals Reported in US Patents

1st Edition

Authors: Thomas F. DeRosa
eBook ISBN: 9780080480916
Hardcover ISBN: 9780080453446
Imprint: Elsevier Science
Published Date: 2nd May 2007
Page Count: 700
Tax/VAT will be calculated at check-out Price includes VAT (GST)
175.00
140.00
215.00
230.00
Unavailable
Price includes VAT (GST)
DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications.

Pharmaceuticals are reported for 27 separate classes of illness, including: AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders.

Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students.

Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications.

Key Features

  • Identifies next generation pharmaceuticals
  • Provides practical preparation methods for each active agent and derivatives
  • Documents the analytical characterization and biological testing results of active agents

Readership

For academic, government, and industrial researchers interested in organic chemistry, medicinal chemistry, natural products, pharmaceuticals, pharmacology and structure-property relationships.

Table of Contents

Acquired Immune Deficiency Syndrome
Addiction Disorders
Alzheimer's Disease
Analgesics
Antibacterial Agents
Anti-inflammatory Agents
Autoimmune Disorders

Cardiovascular Disorders
Diabetes
Diagnostics
Epilepsy
Gastrointestional Disorders
Hepatitis C
Hormonal Disorders
Immunosuppressants
Improved Synthetic Methods
Incontinence
Irritable Bowel Syndrome
Osteoporosis
Malaria
Migraine Headaches
Obesity
Proliferative Disorders
Skin Disorders
Sleep Disorders
Thyroid Disorders
Tinnitus

Details

No. of pages:
700
Language:
English
Copyright:
© Elsevier Science 2007
Published:
Imprint:
Elsevier Science
eBook ISBN:
9780080480916
Hardcover ISBN:
9780080453446

About the Author

Thomas F. DeRosa

Affiliations and Expertise

Southbury, Connecticut, USA